Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Benchmarking variability in semantic segmentation in minimally invasive abdominal surgery.

International journal of computer assisted radiology and surgery·2026

Same author

Family Life and the Integration of Care of a Child With Neurodevelopmental Disability: Parental Experiences and Predictive Factors of Family Functioning, Adjustment and Understanding Disability.

Child: care, health and development·2025

Same author

Colorectal cancer risk mapping through Bayesian networks.

Computer methods and programs in biomedicine·2024

Same author

[Smell and taste disorders in Spanish patients with mild COVID-19].

Neurologia (Barcelona, Spain)·2024

Same author

Occupational injuries in workers of a Spanish bank.

Occupational medicine (Oxford, England)·2023

Same author

Development of Continuum of Care for McArdle disease: A practical tool for clinicians and patients.

Neuromuscular disorders : NMD·2023

Search research articles

Related Experiment Video

Updated: Jul 27, 2026

Getting to Compliance in Forced Exercise in Rodents: A Critical Standard to Evaluate Exercise Impact in Aging-related Disorders and Disease

Getting to Compliance in Forced Exercise in Rodents: A Critical Standard to Evaluate Exercise Impact in Aging-related Disorders and Disease

Published on: August 22, 2014

Does the C34T mutation in AMPD1 alter exercise capacity in the elderly?

M Pérez¹, M A Martin, S Cañete

¹Universidad Europea de Madrid, Madrid, Spain.

International Journal of Sports Medicine

|June 13, 2006

Summary

The C34T mutation in the AMPD1 gene does not appear to impact functional capacity in elderly women. This study found no significant differences in exercise performance or functional tests between carriers and non-carriers of the mutation.

More Related Videos

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

Soft Hip Exoskeleton Reduces Physiological Cost and Perceived Exertion In Older Adults During Uphill Walking

Soft Hip Exoskeleton Reduces Physiological Cost and Perceived Exertion In Older Adults During Uphill Walking

Published on: June 9, 2026

Related Experiment Videos

Last Updated: Jul 27, 2026

Getting to Compliance in Forced Exercise in Rodents: A Critical Standard to Evaluate Exercise Impact in Aging-related Disorders and Disease

Getting to Compliance in Forced Exercise in Rodents: A Critical Standard to Evaluate Exercise Impact in Aging-related Disorders and Disease

Published on: August 22, 2014

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

Soft Hip Exoskeleton Reduces Physiological Cost and Perceived Exertion In Older Adults During Uphill Walking

Soft Hip Exoskeleton Reduces Physiological Cost and Perceived Exertion In Older Adults During Uphill Walking

Published on: June 9, 2026

Area of Science:

Exercise Physiology
Human Genetics
Aging Research

Background:

Aging impairs muscle function, affecting energy production and force generation.
The AMP deaminase (AMPD) enzyme, encoded by AMPD1, regulates muscle metabolism.
The C34T mutation in AMPD1 is common in Caucasians (approx. 20% heterozygous).

Purpose of the Study:

To investigate if heterozygous C34T mutation in AMPD1 affects functional capacity in aging women.
To compare exercise performance and functional tests between elderly women with and without the C34T mutation.

Main Methods:

Twenty-one women (61-80 years) were genotyped for the C34T mutation.
Subjects were divided into two groups: heterozygous for C34T (n=4) and no mutation (n=17).
Maximal and submaximal exercise tests (VO2 peak, ventilatory threshold, peak power) and functional tests (1-mile walk, sit-stand) were performed.

Main Results:

No significant differences were observed between groups in peak oxygen uptake (VO2 peak).
Ventilatory threshold (VT) and mechanical efficiency showed no significant group differences.
Functional tests, including the 1-mile walk test and sit-stand test, yielded comparable results for both groups.

Conclusions:

The heterozygous C34T mutation of the AMPD1 gene does not seem to impair functional capacity in elderly women.
Further research is warranted, but current findings suggest this common mutation does not negatively impact aging muscle function.